Anakinra injection bulk supplier for pharma manufacturers

Anakinra Injection 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection(SQ)

Available Strengths: 100 mg/mL

Reference Brands: Kineret (US)

Anakinra prefilled pens deliver IL-1 receptor antagonism, blocking IL-1 activity involved in inflammation. It effectively reduces symptoms of rheumatoid arthritis, Still’s disease, and other autoinflammatory conditions. Benefits include targeted therapy, ease of administration, consistent dosing, rapid symptom relief, and improved patient adherence, supporting better disease management.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Anakinra Injection? List it or send an offer →

Product Description: Anakinra prefilled pens, marketed as Kineret, are approved in both the US by the FDA and in the EU via EMA for rheumatoid arthritis, Still's disease, and autoinflammatory conditions. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety, manufacturing quality, and pharmacovigilance data. In the US, the FDA reviews detailed clinical trial and manufacturing information, while the EMA ensures compliance with regional standards. Ensuring compliance is essential for timely approval, supporting safe and effective treatment options for autoimmune and autoinflammatory diseases worldwide.

Anakinra Injection — third party manufacturing & bulk supply

Anakinra Injection 100 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Anakinra Injection is supplied as Injection(SQ) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Anakinra Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Anakinra Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Anakinra injection is listed as Injection(SQ) in 100 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Anakinra injection is referenced against Kineret (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.